Phase: Phase III
Type: Health services research, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000561532, WCTU-FRAGMATIC, Velindre-FRAGMATIC, WCTU-02, EU-20753, PFIZER-WCTU-02, EUDRACT-2005-002438-37, ISRCTN80812769, NCT00519805

Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: CDR0000593019, GERCOR-PAM07-D07-2, EUDRACT 2007-002115-59, EU-20837, PFIZER-GERCOR-PAM07-D07-2, NCT00662688

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 25387, 1 R01 HL95109-01, NCT00876915

Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: EudraCT nr: 2009-015336-15, Protocol nr: 29462, NCT01164046

Phase: Phase III
Type: Supportive care
Status: Active
Age: 20 to 75
Sponsor: Other
Protocol IDs: CUMC-GC2011, NCT01448746

Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: PRH-HCTU-FRAGEM, PRH-HCTU-FRAGEM-V-12.1, CTA-MF8000/13558, EU-20721, LILLY-PRH-HCTU-FRAGEM, FRAGEM, ISRCTN76464767, NCT00462852

Phase: Phase II
Type: Supportive care
Status: Active
Age: 0 to 18
Sponsor: Pharmaceutical / Industry
Protocol IDs: FRAG-A001-201, NCT00952380

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 16M-11-1, NCI-2011-03784, NCT01518465

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: I 145508, NCI-2009-01694, NCT01061411